Latest News
View All News
All News
Dr. Nik Gravenstein Joins Xhale Assurance, Inc. as Chief Medical Advisor
Dr. Nik Gravenstein Joins Xhale Assurance, Inc. as Chief Medical…
Xhale Assurance Announces FDA Approval for Pediatric Indication for the Nasal Alar Sp02 Sensor
GAINESVILLE, FL August 31, 2017 – Xhale Assurance, Inc.
Xhale…
Xhale Assurance to Showcase Alar Sensor at AARC
Xhale Assurance and its exclusive distribution partner Tri-anim…
Xhale Assurance to Showcase Alar Sensor at ASA
Xhale Assurance and its exclusive distribution partner Tri-anim…
Xhale Assurance to Showcase Alar Sensor at AACN 2018
Xhale Assurance announced today that it will showcase its Nasal…
Xhale Assurance to Showcase Alar Sensor at SCCM
Xhale Assurance announced today that it will showcase its Nasal…
Xhale Assurance to Showcase Alar Sensor at AANA2017
Xhale Assurance announced today that it will showcase its Nasal…
Xhale submits Biomarker Qualification package to FDA for Medication Adherence Monitoring Tool
Xhale submits Biomarker Qualification package to FDA for Medication…
Xhale Assurance Announces CE Mark for Nasal Alar SpO2 Sensor
Xhale Assurance announced today that it has received CE Mark…
Xhale's Assurance Nasal Alar SpO2 ™ Sensor to be Showcased at National Teaching Institute & Critical Care Exposition
Xhale's Assurance Nasal Alar SpO2 ™ Sensor to be Showcased…
Xhale Assurance Announces FDA Approval of its Second Generation Nasal Alar SpO2 Sensor
Xhale Assurance, Inc., developer of the patented Assurance®…
Xhale's SMART® Adherence Technology Enabled Through Collaboration with Catalent
Xhale announces availability of first solution to enable integration…
Xhale Smart®
Xhale Smart® – Latest News
Xhale submits Biomarker Qualification package to FDA for Medication Adherence Monitoring Tool
Xhale submits Biomarker Qualification package to FDA for Medication…
Xhale's SMART® Adherence Technology Enabled Through Collaboration with Catalent
Xhale announces availability of first solution to enable integration…
Xhale's SMART Technology Showcased at Drug Development, Medication Adherence, and Innovation Meetings
SMART® solution which enables the management of medication adherence…
Xhale Awarded NIH/NIMH SBIR Grant for Monitoring Microbicide Gel Use
GAINESVILLE, FL April 16, 2014 - Xhale SMART, Inc.
Xhale,…
Xhale SMART Achieves Significant Milestone with ISO 13485 Certification
GAINESVILLE, FL December 2, 2013 – Xhale, Inc.
Xhale SMART,…
Xhale’s SMART Biotechnologies Poised to Provide Solutions for Costly Drug Development
GAINESVILLE, FL – February 21, 2013 – Xhale, Inc.
The…
Chief Science Officer of Xhale subsidiary SMART Biotechnologies, Inc. elected an NAI Charter Fellow
The Chief Science Officer of the Xhale, Inc. subsidiary SMART…
SMART Biotechnologies, Inc. Announces the Appointment of Thomas J. Bigger as New Company President
GAINESVILLE, FL – January 8, 2013
SMART Biotechnologies,…
Xhale Awarded National Institute of Drug Abuse (NIDA) Grant for Further Development of Innovative Breath-Based SMART® Adherence Tool.
GAINESVILLE, FL – August 22, 2012
Xhale, Inc. announced…
Xhale Completes NIH-Funded Study on SMART™ Adherence Monitoring System
Xhale, Inc. announced today the successful completion of an NIH-funded…
Xhale Completes Spin Off of SMART Biotechnologies
GAINESVILLE, FL – Oct. 1, 2012 – Xhale, Inc.
Xhale, Inc.…
Xhale Assurance®
Xhale Assurance® – Latest News
Dr. Nik Gravenstein Joins Xhale Assurance, Inc. as Chief Medical Advisor
Dr. Nik Gravenstein Joins Xhale Assurance, Inc. as Chief Medical…
Xhale Assurance Announces FDA Approval for Pediatric Indication for the Nasal Alar Sp02 Sensor
GAINESVILLE, FL August 31, 2017 – Xhale Assurance, Inc.
Xhale…
Xhale Assurance to Showcase Alar Sensor at AARC
Xhale Assurance and its exclusive distribution partner Tri-anim…
Xhale Assurance to Showcase Alar Sensor at ASA
Xhale Assurance and its exclusive distribution partner Tri-anim…
Xhale Assurance to Showcase Alar Sensor at AACN 2018
Xhale Assurance announced today that it will showcase its Nasal…
Xhale Assurance to Showcase Alar Sensor at SCCM
Xhale Assurance announced today that it will showcase its Nasal…
Xhale Assurance to Showcase Alar Sensor at AANA2017
Xhale Assurance announced today that it will showcase its Nasal…
Xhale Assurance Announces CE Mark for Nasal Alar SpO2 Sensor
Xhale Assurance announced today that it has received CE Mark…
Xhale's Assurance Nasal Alar SpO2 ™ Sensor to be Showcased at National Teaching Institute & Critical Care Exposition
Xhale's Assurance Nasal Alar SpO2 ™ Sensor to be Showcased…
Xhale Assurance Announces FDA Approval of its Second Generation Nasal Alar SpO2 Sensor
Xhale Assurance, Inc., developer of the patented Assurance®…
Xhale's Assurance Alar/Nasal SpO2 Sensor to be Showcased at Critical Care and Anesthesia Technology Meetings
Xhale Assurance, Inc., developer of the Alar/Nasal SpO2 Sensor,…
Xhale Assurance™ Appoints John Moscarillo as VP of Commercial Operations
Xhale Assurance announced today the appointment of John Moscarillo…
Xhale Assurance Issued U.S. Patent on Optimized Gas Supply using Photoplethysmography
GAINESVILLE, August 13, 2014 – Xhale, Inc.
Xhale Assurance,…
Xhale Assurance Receives ISO 13485 Certification
GAINESVILLE, FL - April 1, 2014 – Xhale Assurance, Inc.
Xhale…
Assurance® Alar One-SenseTM Pulse Oximetry Sensor to be Presented in Two Clinical Abstracts and an Educational Session at Society for Technology in Anesthesiology Meeting
Research shows faster response time and the ability to identify…
LionsGate Technologies and Xhale Assurance announce a codevelopment agreement to bring the Xhale Alar One-Sense™ Pulse Oximetry Sensor to Mobile Health
Bringing together two leading sensor technologies to offer accurate…
Assurance® Alar One-Sense™ Pulse Oximetry Sensor Highlighted in Three Clinical Presentations at American Society of Anesthesiologists Annual Meeting
A New Technology “Right Under Our Nose” – Highlights Benefits…
Assurance Biosense to Unveil Next-Generation Alar Sensor at the International Anesthesia Research Society Meeting
New Device Surmounts Shortcomings of Existing Fingertip Sensors
GLASTONBURY,…
Assurance Biosense Receives FDA 510(k) Clearance to Market Alar Sensor
Unique Nasal Ala Pulse Oximetry Sensor
Alar Sensing…
Assurance Biosense Announces Key Addition to Executive Team – Jack Auer Joins as Vice President of Marketing
GLASTONBURY, CT — Assurance Biosense, Inc., a subsidiary of…
Assurance Biosense Announces Two New Scientific Abstracts Presented at 2013 Society for Technology in Anesthesia Meeting
GLASTONBURY, CT – January 11, 2013
Study Received an Award…
Assurance Biosense Issued European and Japanese Patents for Unique Pulse Oximetry Sensors and Monitoring Systems
Glastonbury, CT – November 16, 2012
Assurance Biosense,…
Xhale Completes Spin-Off of Assurance Biosense
New wholly owned subsidiary, Assurance Biosense, Inc., will focus…
